Depyrogenation Oven Market By Material, (Stainless Steel AISI 304, Stainless Steel AISI 316 L, By Temperature Range, (Below 50 degree, 50-100 degree, 100-150 degree, Above 200 degree) By Inside Free Volume, (Below 1 m3, 1-2 m3, 2-3 m3, 3-4 m3, Above 4 m3) - Global Review 2021 to 2031

Depyrogenation Oven Market Forecast and CAGR

Depyrogenation is the process of reducing pyrogenic chemicals, such as bacterial endotoxin, by either removing or inactivating them. Depyrogenation can be accomplished using a variety of methods. Dry heat exposure in a depyrogenation oven is the most common method for pharmaceutical packaging components.

According to the latest research by Fact. MR., the Depyrogenation Oven market is projected to grow at more than 5.5% CAGR during the forecast period owing to the growing demand from pharmaceuticals and healthcare industry.

Depyrogenation and sterilization of empty glass and metal items like as ampoules, injection bottles, vials, and stainless steel equipment are the most common uses for ovens. Sterilization of closed bottles with low aqueous solutions and powder medicaments are two further applications.

For dry heat sterilization of pharmaceutical components and products, the depyrogenation oven is widely employed in biotechnology research and development. This procedure is commonly used to remove pyrogens from heat-stable oils, ointments, and powders, as well as heat-stabile components, glassware, and metal parts.

The ovens are designed for the life sciences industry to meet stringent depyrogenation, sterilising, and drying standards. Ovens are finding a new market in the compounding pharmaceutical sector to meet 503B standards connected to the production process, although being used less commonly in pharmaceutical applications.

What is End Use Scenario for Depyrogenation Oven Market?

Hospitals and clinics, biotech and pharmaceutical firms, medical device companies, food and beverage industry, and others make up the end-use section of the depyrogenation oven market. Because of the increased demand for vaccinations and sterile injections, the biotech and pharmaceutical firms will have a revenue share of over 35%.

The segmental demand is augmented by the involvement of various biotech businesses in the development of biologics, antibodies, and cell treatments. The COVID-19 pandemic has enabled sudden surge in the demand for depyrogenation oven sales which is likely to continue over the short term and enable additional revenue generation for market players.

Pharmaceuticals Industry Likely to Augment Dehydrogenation Oven Sales

With a CAGR of 3-6 %, the global pharmaceutical market is predicted to surpass $1.5 trillion by 2023, up from $1.2 trillion in 2018. This rise should be matched by a rise in the number of products launched and growing effect of COVID-19 pandemic outbreak.

The US market is predicted to grow at a quicker rate of 6–7% than the top five European countries growing at 2–4% and Japan as emerging markets is expected to play a major role showing growth of 5–8%. Among these, the Chinese market is expected to achieve a value of $140–170 billion, even if growth slows to 3–6%.

Turkey and Egypt are predicted to expand the most in the next five years, while China, Brazil, and India continue to spend the most on pharmaceuticals. The potential end use of depyrogenation oven in pharmaceuticals industry is likely to grow hand in hand with the mounting pharmaceuticals industry and is expected to reach potential heights.

Asia Pacific Demand Outlook for Depyrogenation Oven

Because of the growing number of biotechnology and pharmaceutical firms in Asia Pacific, the depyrogenation oven market is expected to grow at CAGR of more than 8%. Leading biotech and pharmaceutical companies have a strong presence in the region, which has resulted in increased R&D spending.

Furthermore, the population of Asian countries such as China and Japan is ageing. Several chronic diseases are more common in the elderly population. As a result of this demographic trend, the need for surgical treatments will increase, which will increase the demand for depyrogenation ovens and related equipment.

Due to favorable reimbursement regulations and rising healthcare expenditure, the Indian market grew to capture close to 20% of the market share by 2031. In India, the growing number of medical procedures has resulted in better sterility and depyrogenation equipment that successfully regulates patient health.

Furthermore, several government programs for the cleaning and disinfection of surgical devices used in healthcare facilities would help the prominent market players to expand during the forecast period.

Who are the Key Manufacturers and Suppliers of Depyrogenation Oven?

Some of the prominent players in the depyrogenation oven are

• Lytzen
• Avantor
• Despatch
• Fedegari Group
• Telstar
• Stericox and Biometrix Corporation.

These players holds the prominent market share of global depyrogenation oven market.

Manufacturers are also bestowing their R&D technologies in order to provide high end and customized products and services. In order to gain substantial market share, manufacturers are shifting towards mergers & acquisitions and deliberate partnerships to reinforce their product range and provide viable variations.

Depyrogenation Oven Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Key Segments

• By Material

  • Stainless Steel AISI 304
  • Stainless Steel AISI 316 L
  • Others

• By Temperature Range

  • Below 50 degree
  • 50-100 degree
  • 100-150 degree
  • 150-200 degree
  • Above 200 degree

• By Inside Free Volume

  • Below 1 m3
  • 1-2 m3
  • 2-3 m3
  • 3-4 m3
  • Above 4 m3

• By Vials Capacity (of 10 ml)

  • Below 10,000
  • 10,000 to 25,000
  • 25,000 to 40,000
  • 40,000 to 60,000
  • Above 60,000

• By End Use

  • Hospitals & Clinics,
  • Biotech and Pharmaceutical companies,
  • Medical Device Companies,
  •  Food & Beverage Industry
  • Others

• By Region

  • North America
    • US & Canada
  • Latin America
    • Brazil, Mexico, Argentina & Rest of Latin America
  • Europe
    • Germany, France, Italy, Spain, U.K., Benelux, Russia, and Rest of Europe
  • East Asia
    • China, Japan, South Korea
  • South Asia
    • India, Thailand, Malaysia, Indonesia and Rest of South Asia
  • Oceania
    • Australia and New Zealand
  • Middle East and Africa
    • GCC Countries, Turkey, South Africa, and Rest of Middle East & Africa

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments by product type, by end use industry type and by geographies.

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company